Annenberg Center for Health Sciences
Perspectives on Selected Myasthenia Gravis Posters and Abstracts From AANEM
重症筋無力症の治療における最新の研究の進展を探求し、患者の生活の質の向上と治療の限界に対処する専門家の洞察に焦点を当てます。
Wrap Up
2 mins • Nov 19, 2024
Charts
This show is not currently ranked in any charts.
最近のエピソード
Nov 19, 2024
Wrap Up
2 mins
Nov 19, 2024
Long-Term Safety and Efficacy of Zilucoplan in Generalized Myasthenia Gravis 120-Week Interim Analysis of RAISE-XT
3 mins
Nov 19, 2024
Efficacy and Safety of Nipocalimab in Patients with Generalized Myasthenia Gravis: Topline Results from the Double-Blind, Placebo-Controlled, Randomized Phase 3 VIVACITY-MG3 Study
3 mins
Nov 19, 2024
Concomitant Corticosteroid Use with Ravulizumab in Adults with Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Phase 3 CHAMPION-MG Open-Label Extension Final Results
3 mins
Nov 19, 2024
Cyclic and Every-Other-Week Dosing of Intravenous Efgartigimod for Generalized Myasthenia Gravis Part A of ADAPT NXT
3 mins
言語
英語
国
アメリカ合衆国
Feed Host
ウェブサイト
フィード
更新をリクエストする
更新には数分かかる場合があります。